Prolactin and prolactin-like polypeptides in rheumatoid arthritis

Biomedicine and Pharmacotherapy

Volumn 53, Issue 5-6, 1999, Pages 218-222

  Neidhart, M ^a   Gay, R E ^a   Gay, S ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Prolactin; Proliferin; Rheumatoid arthritis; Synovial cells

Indexed keywords

BROMOCRIPTINE MESILATE; CATHEPSIN; DOPAMINE 2 RECEPTOR STIMULATING AGENT; MATRIX METALLOPROTEINASE; PROLACTIN;

ANIMAL CELL; ANIMAL TISSUE; FEMALE; HORMONAL REGULATION; HYPERPROLACTINEMIA; IMMUNOREACTIVITY; MOUSE; NEGATIVE FEEDBACK; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; RISK FACTOR; T LYMPHOCYTE ACTIVATION;

EID: 0033149861     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0753-3322(99)80091-2     Document Type: Article

References (44)

1. Neidhart M, Flückiger EW. Hyperprolactinemia in hypophysectomized or intact rats and the development of adjuvant arthritis. Immunology 1992 ; 77 : 449.
2. Neidhart M. Elevated serum prolactin or elevated prolactin/cortisol ratio are associated with autoimmune processes in systemic lupus erythematosus and other connective tissue diseases. J Rheumatol 1996 ; 23 : 374.
3. Neidhart M. Prolactin in autoimmunity. Proc Soc Exp Biol Med 1998 ; 217 : 408.
4. Gay S, Gay RE, Koopman WJ. Molecular and cellular mechanisms of joint destruction in rheumatoid arthritis: Two cellular mechanisms explain joint destruction? Ann Rheum Dis 1993 ; 1 : S39.
5. Neidhart M, Gay RE, Gay S. Genetic markers in joint diseases. In: Seibel MJ, Robins SP, Bilezikian JP, eds. Dynamics of Bone and Cartilage Metabolism: Principles and Clinical Applications. San Diego CA: Academic Press; 1999, in press.
6. + cells, is significantly elevated in rheumatoid synovial fluid and produced by synovial fibroblast-like cells. Eur J Immunol 1998 ; 28 : 2661.
7. Jorgensen C, Bressot N, Bologna C, Sany J. Dysregulation of the hypothalamo-pituitary axis in rheumatoid arthritis. J Rheumatol 1995 ; 22 : 1829.
8. Jorgensen C, Maziat H, Bologna C, Sany J. Kinetics of prolactin release in rheumatoid arthritis. Clin Exp Rheumatol 1995 ; 13 : 705.
9. Brennan P, Ollier B, Worthington J, Hajeer A, Silman A. Are both genetic and reproductive associations with rheumatoid arthritis linked to prolactin? Lancet 1996 ; 348 : 106.
10. Brennan P, Hajeer A, Ren Ong K, Worthington J, John S, Thompson W, et al. Allelic markers close to prolactin are associated with HLA-DRB1 susceptibility alleles among women with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum 1997 ; 40 : 1383.
11. Kawai T, Katoh K, Tani K. Hyperprolactinemia preceding development of autoimmune disease. J Rheumatol 1996 ; 23 : 1483.
12. Prokaeva TB, Alekberova ZS, Folomeev M, Mataradze GD. Clinical characteristics of disorders of sexual functions in patients with rheumatoid arthritis. Revmatologiia Mosk 1991 ; 18 : Jan-Mar.
13. Mateo L, Nolla JM, Bonnin MR, Navarro MA, Roig-Escofet D. High serum prolactin levels in men with rheumatoid arthritis. J Rheumatol 1998 ; 25 : 2077.
14. Eulry F, Mayaudon H, Bauduceau B, Lechevalier D, Crozes P, Magnin J, et al. Blood prolactin under the effect of protirelin in spondylarthropathies. Treatment trial of four cases of reactive arthritis and two cases of psoriatic arthritis with bromocriptine. Ann Med Intern Paris 1996 ; 147 : 15.
15. Halko G, Urrows S, Affleks G, Waterman J. Serum prolactin levels and disease activity in rheumatoid arthritis. Arthritis Rheum 1995 ; 38 Suppl : S289.
16. Leanos-Miranda A, Pascoe-Lira D, Blanco-Favela F. Prolactin and systemic lupus erythematosus. Br J Rheumatol 1998 ; 37 : 1029.
17. Chikanza IC, Petrou P, Chrousos G, Kingsley G, Panayi GS. Excessive and dysregulated secretion of prolactin in rheumatoid arthritis: Immunopathogenetic and therapeutic implications. Br J Rheumatol 1993 ; 32 : 445.
18. Zautra AJ, Burleson MH, Matt KS, Roth S, Burrows L. Interpersonal stress, depression, and disease activity in rheumatoid arthritis and osteoarthritis patients. Health Psychol 1994 ; 13 : 139.
19. Kullich WC, Klein G. High levels of macrophage inflammatory protein-1α correlate with prolactin in female patients with active rheumatoid arthritis. Clin Rheumatol 1998 ; 17 : 263.
20. Picco P, Gattorno M, Buoncompagni A, Fachetti P, Rossi G, Pistoia V. Prolactin and interleukin-6 in prepubertal girls with juvenile chronic arthritis. J Rheumatol 1998 ; 25 : 347.
21. Whyte A, Williams RO. Bromocriptine suppresses postpartum exacerbation of collagen-induced arthritis. Arthritis Rheum 1988 ; 31 : 927.
22. Bazan JF. Structural design and molecular evolution of a cytokine receptor family. Proc Natl Acad Sci USA 1988 ; 83 : 6934.
23. Hiestand PC, Meckler P, Nordmann R, Grieder A, Permmongkol C. Prolactin as a modulator of lymphocyte responsiveness provides a possible mechanism for cyclosporin. Proc Natl Acad Sci USA 1988 ; 83 : 2599.
24. Leite-de-Moraes MC, Touraine P, Gagnereault MC, Savino W, Kelly PA, Dardenne M. Prolactin receptors and the immune system. Ann Endocrinol Paris 1995 ; 56 : 4165.
25. Richards RG, Hartman SM. Human dermal fibroblast T-cells express prolactin in vitro. J Invest Dermatol 1996 ; 106 : 1250.
26. Nagafuchi H, Suzyki N, Tsuboi S, Asai T, Sakane T. Local paracrine loop by prolactin for aggravation of synovial lesions in patients with rheumatoid arthritis. Arthritis Rheum 1997 ; 40 Suppl : S253.
27. Sabharwal P, Glaser R, Lafuse W, Varma S, Liu Q, Arkins S, et al. Prolactin synthesized and secreted by human peripheral blood mononuclear cells: An autocrine growth factor for lympho-proliferation. Proc Natl Acad Sci USA 1992 ; 89 : 7713.
28. Pellegrini I, Lebrun JJ, Ali S, Kelly PA. Expression of prolactin and its receptor in human lymphoid cells. Mol Cell Endocrinol 1992 ; 6 : 1023.
29. Matera L. Action of pituitary and lymphocyte prolactin. Neuroimmunomodulation 1997 ; 4 : 171.
30. Linzer DI, Nathans D. Nucleotide sequence of a growth-related mRNA encoding a member of the prolactin/growth hormone family. Proc Natl Acad Sci USA 1984 ; 81 : 4255.
31. Groskopf JC, Syu LJ, Saltiel AR, Linzer DI. Proliferin induces endothelial cell chemotaxis through a G protein-coupled, mitogen-activated protein kinase-dependent pathway. Endocrinology 1997 ; 138 : 2835.
32. Nilsen-Hamilton M, Jang YJ, Delgado M, Shim JK, Bruns K, Chiang CP, et al. Regulation of the expression of mitogen-regulated protein (MRP, proliferin) and cathepsin L in cultured cells and in the murine placenta. Mol Cell Endocrinol 1991 ; 77 : 115.
33. Nagafuchi H, Suzuki N, Kaneko A, Asai T, Sakane T. Mechanism by which prolactin produced by synovial cells and synovium-infiltrating T-lymphocytes augments synovial cell function in patients with rheumatoid arthritis. Arthritis Rheum 1998 ; 41 Suppl : S277.
34. Gouilleux F, Moritz D, Humar M, Moriggi R, Berthold S, Groner B. Prolactin and interleukin-2 receptors in T-lymphocytes signal through an MGF-STAT5-like transcription factor. Endocrinology 1995 ; 136 : 5700.
35. Trabandt A, Aicher WK, Gay RE, Sukhatme VP, Fassbender HG, Gay S. Spontaneous expression of immediately-early responses genes c-fos and egr-1 in collagnase-producing rheumatoid synovial fibroblasts. Rheumatol Int 1992 ; 12 : 53.
36. MÜller-Ladner U, Kriegsmann J, Gay RE, Gay S. Oncogenes in rheumatoid arthritis. Rheum Dis Clin North Am 1995 ; 21 : 675.
37. Das R, Vonderhaar BK. Involvement of SHC, GRB2, SOS, and RAS in prolactin signal transduction in mammary epithelial cells. Oncogene 1996 ; 13 : 1139.
38. Camarillo IG, Rillema JA. Lovastatin inhibits prolactin- induced Nb2 cell mitogenesis and milk product synthesis in mouse mammary gland explants. Proc Soc Exp Biol Med 1997 ; 216 : 98.
39. Berczi I, Nagy E, de Toledo SM, Matusik RJ, Friesen HG. Pituitary hormones regulate c-myc and DNA synthesis in lymphoid tissue. J Immunol 1991 ; 146 : 2201.
40. Rao Y, Buckley DJ, Buckley AR. Rapid activation of mitogen- activated protein kinase and p21 ras by prolactin and interleukin-2 in rat Nb2 node lymphoma cells. Cell Growth Diff 1987 ; 6 : 11.
41. Trabandt A, Aicher WK, Gay RE, Sukhatme VP, Nilson HM, Hamilton RT, et al. Expression of the collagenolytic and ras-induced cystein proteinase cathepsin L and proliferation-associated oncogenes in synovial cells of MRL/1 mice and patients with rheumatoid arthritis. Matrix 1990 ; 10 : 349.
42. Jikihara H, Handwerker S. Tumor necrosis factor-alpha inhibits the synthesis and release of human decidual prolactin. Endocrinology 1994 ; 134 : 353.
43. Neidhart M. Suppression of prolactin release as therapy for autoimmune diseases? Trends Immunol 1998 ; 1 : 97.
44. Neidhart M. Bromocriptine has little direct effect on murine lymphocytes, the immunomodulatory effect being mediated by the suppression of prolactin secretion. Biomed Pharmacother 1997 ; 51 : 118.